Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03033680Phase 2Completed
Phase 2, open-label, single-arm trial, sponsored by Brigham and Women's Hospital. Primary endpoint: Tissue Volume of Distribution at 1 month. Started Mar 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03033680.